These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34004255)

  • 1. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
    Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
    Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
    Nagapoosanam AL; Ganesan N; Umapathy D; Moorthy RK; Arockiam AJV
    Indian J Med Res; 2019 Mar; 149(3):345-353. PubMed ID: 31249199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
    Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
    Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
    Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
    Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models.
    Zhang M; Hagan CT; Min Y; Foley H; Tian X; Yang F; Mi Y; Au KM; Medik Y; Roche K; Wagner K; Rodgers Z; Wang AZ
    Biomaterials; 2018 Jul; 169():1-10. PubMed ID: 29631163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
    Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
    Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment.
    Lu X; Zhang Y; Wang L; Li G; Gao J; Wang Y
    Drug Deliv; 2021 Dec; 28(1):380-389. PubMed ID: 33586561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.
    Luiz MT; Abriata JP; Raspantini GL; Tofani LB; Fumagalli F; de Melo SMG; Emery FDS; Swiech K; Marcato PD; Lee R; Marchetti JM
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110038. PubMed ID: 31546359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
    Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
    J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene silencing effect of SiRNA-magnetic modified with biodegradable copolymer nanoparticles on hTERT gene expression in lung cancer cell line.
    Fekri Aval S; Akbarzadeh A; Yamchi MR; Zarghami F; Nejati-Koshki K; Zarghami N
    Artif Cells Nanomed Biotechnol; 2016; 44(1):188-93. PubMed ID: 25020049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application.
    Jafari-Gharabaghlou D; Dadashpour M; Khanghah OJ; Salmani-Javan E; Zarghami N
    Mol Biol Rep; 2023 Apr; 50(4):3023-3033. PubMed ID: 36662452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Nanomedicine (Lond); 2018 Nov; 13(21):2729-2758. PubMed ID: 30394201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line.
    Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
    Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
    Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.